XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities:    
Net loss $ (5,625,749) $ (6,317,024)
Adjustment to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 1,356,389 1,125,101
Issuance of restricted shares in exchange for services 138,500 0
Interest accrued on license payable 5,062 5,063
Changes in operating assets and liabilities:    
Prepaid assets and other current assets 98,552 207,119
Other assets 0 110,548
Accounts payable (322,797) 622,162
Accrued compensation 297,509 349,437
Other accrued expenses (964,793) (721,146)
Net cash used in operating activities (5,017,327) (4,618,740)
Financing Activities:    
Proceeds from sale of shares under At-the-Market Facility, net 519,624 0
Payment of taxes from withholding of common stock on settlement of restricted stock units (527,716) 0
Deferred offering costs 0 (133,477)
Net cash used in financing activities (8,092) (133,477)
Net change in cash and cash equivalents (5,025,419) (4,752,217)
Cash and cash equivalents, beginning of period 13,159,423 8,641,622
Cash and cash equivalents, end of period 8,134,004 3,889,405
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 0
Cash paid for income taxes 800 800
Supplemental Schedule of Noncash Financing Activities:    
Deferred offering costs charged against At-the-Market Facility 653 0
Deferred offering costs, unpaid and accrued $ 0 $ 100,998